183 related articles for article (PubMed ID: 38370338)
1. MicroRNA-329-3p inhibits the Wnt/β-catenin pathway and proliferation of osteosarcoma cells by targeting transcription factor 7-like 1.
Sun H; Kawano M; Iwasaki T; Itonaga I; Kubota Y; Tsumura H; Tanaka K
Oncol Res; 2024; 32(3):463-476. PubMed ID: 38370338
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
Xue Y; Guo Y; Liu N; Meng X
Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
[TBL] [Abstract][Full Text] [Related]
4. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway.
Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G
Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
[No Abstract] [Full Text] [Related]
6. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
Bi W; Yang M; Xing P; Huang T
Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
[TBL] [Abstract][Full Text] [Related]
7. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.
Dong L; Qu F
J Mol Histol; 2020 Aug; 51(4):329-340. PubMed ID: 32472335
[TBL] [Abstract][Full Text] [Related]
8. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
10. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
11. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
Yang G; Zhang C; Wang N; Chen J
Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
13. Circ_0003732 promotes osteosarcoma progression through regulating miR-377-3p/CPEB1 axis and Wnt/β-catenin signaling pathway.
Zhou Z; Liu T; Li Z; Wang L
Anticancer Drugs; 2022 Jan; 33(1):e299-e310. PubMed ID: 34407049
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
Zhang Q; Yin X; Zhang Y
Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
[TBL] [Abstract][Full Text] [Related]
15. hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt/beta-catenin signaling pathway.
Zhu D; Qi H; Zhu H
Sci Rep; 2023 Aug; 13(1):12544. PubMed ID: 37532779
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
[TBL] [Abstract][Full Text] [Related]
17. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
Xu H; Li B
Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis.
Xia P; Gu R; Zhang W; Shao L; Li F; Wu C; Sun Y
J Cell Physiol; 2019 Dec; 234(12):22787-22798. PubMed ID: 31152456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
